title: Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy.
abstract: Inconsistencies permeate the literature regarding small bowel dose tolerance limits for stereotactic body radiation therapy (SBRT) treatments. In this review, we organized these diverse published limits with MD Anderson at Cooper data into a unified framework, constructing the dose-volume histogram (DVH) Risk Map, demonstrating low-risk and high-risk SBRT dose tolerance limits for small bowel. Statistical models of clinical data from 2 institutions were used to assess the safety spectrum of doses used in the exposure of the gastrointestinal tract in SBRT; 30% of the analyzed cases had vascular endothelial growth factor inhibitors (VEGFI) or other biological agents within 2 years before or after SBRT. For every dose tolerance limit in the DVH Risk Map, the probit dose-response model was used to estimate the risk level from our clinical data. Using the current literature, 21Gy to 5cc of small bowel in 3 fractions has low toxicity and is reasonably safe, with 6.5% estimated risk of grade 3 or higher complications, per Common Terminology Criteria for Adverse Events version 4.0. In the same fractionation for the same volume, if lower risk is required, 16.2Gy has an estimated risk of only 2.5%. Other volumes and fractionations are also reviewed; for all analyzed high-risk small bowel limits, the risk is 8.2% or less, and the low-risk limits have 4% or lower estimated risk. The results support current clinical practice, with some possibility for dose escalation.
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ.
authors.forename: Tamara A
authors.initials: TA
authors.lastname: LaCouture
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ.
authors.forename: Jinyu
authors.initials: J
authors.lastname: Xue
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ.
authors.forename: Gopal
authors.initials: G
authors.lastname: Subedi
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ.
authors.forename: Qianyi
authors.initials: Q
authors.lastname: Xu
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ.
authors.forename: Justin T
authors.initials: JT
authors.lastname: Lee
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ.
authors.forename: Gregory
authors.initials: G
authors.lastname: Kubicek
authors.affiliation: MD Anderson at Cooper University Hospital, Camden, NJ. Electronic address: asbell-sucha@cooperhealth.edu.
authors.forename: Sucha O
authors.initials: SO
authors.lastname: Asbell
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D007421:Intestine, Small / Q000528:radiation effects*; D011832:Radiation Injuries / Q000517:prevention & control; D011836:Radiation Tolerance; D016634:Radiosurgery / Q000379:methods*